title: Percutaneous coronary intervention without on site surgical back-up; two-years registry of a large Dutch community hospital.
abstract: OBJECTIVE
  To assess safety and efficacy of off-site percutaneous coronary intervention (PCI) in The Dutch invasive cardiovascular system.
  
  
  RESULTS
  Descriptive single centre registry of elective and emergency PCI. Setting is a Dutch community hospital, 40 km north of Amsterdam, with an adherent population of 400,000 people. A Clinical follow up of Major Adverse Cardiac and Cerebral Events (MACCE) at 30 days post PCI is performed. The total number of participants eligible for PCI was 781 of whom 545 were men and 236 women. During a two-year period 781 PCI's were performed of which 298 were emergency and 483 elective. Acute complications occurred in 2.1% of participants. MACCE-free was 86.9% in the group with AMI and 95.8% in the elective group.
  
  
  CONCLUSIONS
  Off-site PCI is feasible and safe in The Netherlands on the condition that specific key factors for success are taken into consideration.
authors.affiliation: Department of Cardiology, Medical Centre Alkmaar, Wilhelminalaan 12, PBX 501, 1800 AM, Alkmaar, The Netherlands.
authors.forename: J O J
authors.initials: JO
authors.lastname: Peels
authors.forename: R W M
authors.initials: RW
authors.lastname: Hautvast
authors.forename: J B R M
authors.initials: JB
authors.lastname: de Swart
authors.forename: M A J M
authors.initials: MA
authors.lastname: Huybregts
authors.forename: V A W M
authors.initials: VA
authors.lastname: Umans
authors.forename: A E R
authors.initials: AE
authors.lastname: Arnold
authors.forename: G A J
authors.initials: GA
authors.lastname: Jessurun
authors.forename: F
authors.initials: F
authors.lastname: Zijlstra
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000592:standards / Q000706:statistics & numerical data*; D000077144:Clopidogrel; D005240:Feasibility Studies; D005260:Female; D006764:Hospitals, Community / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D009426:Netherlands / Q000453:epidemiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012042:Registries; D012307:Risk Factors; D012449:Safety; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine